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ABSTRACT  Infants rely on brown adipose tissue (BAT) as a primary source of thermogenesis. In some adult humans, residuals of brown adi-
pose tissue are adjacent to the central nervous system and acute activation increases metabolic rate. Brown adipose tissue (BAT) recruitment 
occurs during cold acclimation and includes secretion of factors, known as batokines, which target several different cell types within BAT, and 
promote adipogenesis, angiogenesis, immune cell interactions, and neurite outgrowth. All these processes seem to act in concert to promote an 
adapted BAT. Recent studies have also provided exciting data on whole body metabolic regulation with a broad spectrum of mechanisms involving 
BAT crosstalk with liver, skeletal muscle, and gut as well as the central nervous system. These widespread interactions might reflect the property 
of BAT of switching between an active thermogenic state where energy is highly consumed and drained from the circulation, and the passive 
thermoneutral state, where energy consumption is turned off. (Endocrine Reviews 41: 53 – 65, 2020)
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I t is well established that adipose tissue is an important contributor to the regulation of 
energy metabolism through organ crosstalk. This is 
exemplified by adipokines secreted from mainly 
white adipose tissue (WAT) including leptin and 
adiponectin, which are released as a response to a 
certain energetic state (1, 2). Since the discovery 
that adult humans have functionally competent 
brown adipose tissue (BAT) (3–7), multiple studies 
have addressed its function in energy metabolism. 
It was shown that in adult humans active BAT con-
tent is negatively correlated with body mass index 
(BMI) (4, 5) and in vivo studies suggest a func-
tional role of BAT in whole-body metabolism (8–
12). Importantly, studies using fluorine-18 
fludeoxyglucose (18F-FDG)-positron emission to-
mography/ computed tomography (PET/CT) 
scanning following cooling suggest that not all 
individuals have cold-responsive BAT, revealing a 
loss of a potentially important metabolic function 
in a large part of the population (4, 13–16). 
Although minor increases in BAT response fol-
lowing repeated cold exposure have been reported 
(11, 17, 18), BAT activation is clearly associated 
with age (15, 16) and no satisfactory approach to 
efficiently restore functional BAT in aging and 
obese subjects has been reported to date. Studying 
secreted factors from metabolically active BAT, 
known as batokines, offers an alternative approach 
to identify novel drug targets for metabolic regula-
tion. Batokines have autocrine, paracrine, or endo-
crine activities, and excellent and extensive reviews 
on these secreted factors from BAT have recently 
been provided (19, 20). However, current reports 
on batokines are mostly based on studies in mouse 
models, while data on human batokines are lim-
ited. Given the obvious differences between mice 
and humans in terms of thermogenic needs and 
metabolism, we cannot assume a complete overlap. 
In this review, we aim to leverage current under-
standing of the functional spectra of batokines by 
acknowledging the cellular and energetic com-
plexity of BAT. We provide a structure for the 
processes and cell types involved in BAT recruit-
ment and we discuss recent findings of BAT cross-
talk in whole-body metabolism. Finally, we discuss 
the plasticity of BAT in the perspective of human 
physiology and highlight some reported differences 
in batokines between human and mice.
Brown Adipose Tissue in Infants versus 
Adult Humans
Autopsy morphological mapping (21, 22) and 
post-mortem magnetic resonance imaging (MRI) 
scanning (23) have revealed substantial amounts 
of BAT in human infants, suggesting that this fat 
is a necessary regulator of body temperature in 
early life when muscle shivering is not yet devel-
oped (24). This heat production is probably also 
the most important function in small mammals, 
such as the widely studied rodents (25). An exten-
sive post-mortem mapping of brown adipocytes 
in human adipose tissues from infancy and up 
to 80  years of age revealed a gradual change in 
BAT morphology (22). During the first decade of 
age, multilocular adipocytes were abundant and 
contained only small amounts of lipids. Although 
declining in frequency among individuals, this 
phenotype was found up to the age of 20. After this, 
multilocular adipocytes were still found; however, 
these cells were more lipid filled (22).
In adult humans, the superficial interscapular 
BAT has disappeared. However, active BAT can, 
especially in younger adults, be found in the su-
perficial supraclavicular depot as well as the 
deeper depots, aligning the kidney and the spinal 
cord up to the neck (3–7). A  direct quantitative 
comparison between infants and adults is difficult 
to perform due to the limitations in the current 
methodology of determining amounts of active 
BAT, which relies on acute cooling in combina-
tion with injection of 18F-FDG, a radioactive glu-
cose tracer, prior to PET and CT scanning. While 
this approach can be used in adults, it cannot 
be performed in infants. The gradual changes in 
BAT appearance adds to the complexity in direct 
comparisons of BAT abundance between infants 
and adults.
Interestingly, similarly to small mammals 
(25), adult BAT activity is increased in associ-
ation with a meal and is linked to uptake of cir-
culatory fatty acids and glucose (26), suggesting 
ESSENTIAL POINTS
 • Recruitment of brown adipose tissue (BAT) includes secretion of factors, known as batokines
 • Batokines act on cells within the adipose tissue and promote adipogenesis, angiogenesis, immune cell interactions, and 
neurite outgrowth
 • BAT is part of an interorgan crosstalk with liver, skeletal muscle, and gut as well as the central nervous system
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a cold-independent, albeit still sympathetically 
regulated, role of BAT in promoting metabolic 
homeostasis. Notably, as mentioned above, the 
morphology of BAT in adult humans differs from 
that of infants and is characterized by a hetero-
geneous mixture of unilocular and multilocular 
adipocytes with a higher fat content than is seen 
in the homogeneously multilocular infant BAT (6, 
22, 27, 28). In this respect, infant BAT resembles 
intrascapular BAT of mice housed at temperatures 
below thermoneutrality, while BAT from adults has 
the morphology of inguinal WAT of mice housed 
under cold conditions or interscapular BAT of mice 
housed at thermoneutrality (29). Thus, BAT mor-
phology seems to reflect the usage or activity of the 
tissue. It is a long-standing debate whether inter-
conversion occurs between brown adipocytes and 
white adipocytes (30) and whether this constitutes 
an uni- or a bidirectional process. It was shown 
that differentiation of thermogenic adipocytes in 
WAT during cold acclimation occurred through de 
novo recruitment of preadipocytes (31). However, 
it remains unclear whether white interconversion 
of brown adipocytes is due to a cell identity switch 
or due to the formation of an “inactive” “or dor-
mant” brown adipocyte state (32). However, a re-
cent study on perirenal BAT in adults demonstrates 
the presence of unilocular adipocytes which are 
mitochondrial brown fat uncoupling protein 1 
(UCP1) positive, and the stromal vascular frac-
tion of adipose biopsies in this region contained 
preadipocytes that differentiated into thermogenic 
adipocytes in vitro (27). Altogether, these findings 
emphasize the plasticity of BAT and seem to reflect 
a continuous environment-dependent adaptation 
of this tissue. While sympathetic activity probably 
is a major overarching regulator of this plasticity, 
downstream mediators, ie, “batokines,” acting spe-
cifically on the different cell types composing BAT, 
could be valuable tools for increasing the amount of 
mature active brown adipocytes in adult humans.
BAT plasticity and batokines
BAT is composed of 20% to 30% mature adipocytes 
(33) and a stromal vascular fraction in which ad-
ipose stem cells, preadipocytes, endothelial cells, 
hematopoietic cells, and neural cells reside (Fig. 1). 
In WAT, which is similarly composed (33), it has 
been observed that major differences in adipose-
resident immune cell population occurs in relation 
to obesity, providing systemic low-grade inflamma-
tion (34, 35). Less is known about changes to cel-
lular composition in BAT during obesity. However, 
studies in adult humans show that BAT interacts 
with the environment and adapts to thermal 
conditions (11, 17, 18, 36, 37). Cold acclimation 
requires multiple cell types within the adipose 
tissue including the following. (1) Metabolic ac-
tivity of the mature adipocytes, which is an acute re-
sponse mediated by adrenergic signaling, resulting 
in lipolysis of intracellular triglycerides fueling an 
increased mitochondrial uncoupled respiration 
(25). (2) angiogenesis, which allows an increased 
influx of oxygen for the uncoupled respiration and 
glucose and lipids to replenish energy sources. (3) 
Immunometabolism, a complex interplay between 
immune cells and adipocytes and, finally, (4) neurite 
outgrowth enhancing upcoming sympathetic acti-
vation and afferent signaling to the central nervous 
system (CNS). Several cell types thus coexist within 
BAT that are all affected by and contribute to cold 
acclimation. Multiple growth factors, cytokines, and 
chemokines have been shown to be released from 
both mature and thermogenically activated brown 
adipocytes (19, 20, 38, 39). Determining which cells 
these factors are targeting and how they affect the 
cells could provide us with keys to leverage our un-
derstanding about how childhood levels of BAT can 
be restored in adult humans.
Metabolic activity in thermogenic BAT
Batokines proposed to increase BAT activity are 
frequently linked to enhancing energy uptake of 
glucose and lipids (19, 40). Some batokines have 
been shown to be released from activated brown 
adipocytes and to act in a feedback loop to promote 
BAT activity. For example adenosine, a biproduct 
of norepinephrine production, is released locally 
by BAT and has been shown to activate BAT in 
rodents (41). The physiological effect of adenosine 
was further explored by intravenous injections of 
adenosine in humans, and subsequent estimation 
of BAT activity by measuring perfusion using PET/
CT imaging with [15O]H2O. Strikingly, the effect 
of adenosine was higher than the effect of cold, 
highlighting the importance of adenosine in BAT 
activation (42).
Early studies identifying active BAT in adult 
humans could declare an increased uptake of the 
glucose tracer, 18F-FDG, from the circulation fol-
lowing acute cooling. More recent studies have ap-
plied so-called dynamic PET/CT scanning, where 
the rates of glucose uptake can be determined, 
rather than just a snapshot of glucose uptake at a 
given timepoint (43, 44). This allows more phys-
iologically relevant comparisons between dif-
ferent subject groups. Using this approach, the 
response in BAT glucose uptake rate to acute cold 
challenge could be determined to be between 
80  ±  14  nmol  g−1  min−1 (in noncold-acclimated 
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subjects) and 209  ±  50  nmol  g−1  min−1 (in cold-
acclimated subjects) (45).
Glucose is however not considered to be the 
main substrate for BAT thermogenesis in adult 
humans. Interestingly, a study using microdialysis 
of supraclavicular BAT demonstrated that a large 
portion of the glucose absorbed during cooling is 
subject to anaerobic metabolism and released as 
lactate (46). Cold-induced sympathetic activity 
results in increased levels of circulating fatty acids 
from white adipose tissue (47–50) and studies 
using the PET tracer 14(R,S)-[18F]-fluoro-6-
thia-heptadecanoic acid (18FTHA) (a long-chain 
fatty acid analog) demonstrates a robust uptake. 
Although the uptake of non-esterified fatty acids 
(NEFA) in BAT during cold activation was asso-
ciated with BAT thermogenesis (26), this tracer 
is trapped in the mitochondrial matrix and thus 
not suitable as a marker for estimating the extent 
of oxidative metabolism. However, it can be used 
for estimation of relative fatty acid uptake be-
tween tissues. In this respect, it was determined 
that during cooling, BAT dietary fatty acid uptake 
was 2-fold higher than in the neck subcutaneous 
WAT, and 3-fold higher in skeletal muscle (51).
Nevertheless, it has been suggested that BAT of 
adult humans utilize intracellular sources of energy 
as a first choice, for inhibition of lipolysis resulted 
in increased shivering, ie, a switch to muscular 
thermogenesis (48).
In sharp contrast, rodents seem to be more de-
pendent on energy uptake from the circulation for 
providing enough fuel for BAT thermogenesis. The 
energy uptake of active BAT is high and results 
in a substantial effect on triglyceride clearance 
(52). Furthermore, a knockout model of adipose 
Mature adipocytes
(20-30%)
Brown adipose tissue
Batokines
Stromal vascular fraction
(70-80%)
Endothelial cells
Hematopoietic cells
Neural cells
Preadipocytes Adipogenesis
Angiogenesis
Immunometabolism
Neurite outgrowth
Metabolic activity
1
2
3
Figure 1. Batokine-mediated processes during brown adipose tissue (BAT) recruitment. Adipose tissue is composed of mature adipo-
cytes (20% to 30%) and a stromal vascular fraction with a dynamic composition of preadipocytes, endothelial cells, hematopoietic cells 
and neural cells. Batokines are produced by the mature brown adipocytes and can (1) act on other tissues in an endocrine fashion; (2) en-
hance thermogenic activity; (3) induce processes involved in BAT recruitment including adipogenesis, angiogenesis, immunometabolism, 
neurite outgrowth.
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triglyceride lipase, a key enzyme in the lipolysis 
of intracellular fat storage, demonstrated an un-
changed nonshivering thermogenesis. These data 
suggest that energy uptake from the circulation 
provides sufficient fuel for BAT activity in rodents 
(53).
This discrepancy between human and rodents 
could be related to substantial differences in in-
tracellular lipid storage where adult humans have 
much more stored triglycerides than the standard 
mouse model. Interestingly, housing mice at 
thermoneutrality on a high-fat diet, provides a 
“humanized BAT mouse” with comparable lipid ac-
cumulation in BAT (54) and thus providing a more 
suitable model for studying BAT substrate metab-
olism. It is possible that thermogenic substrate up-
take is supported by factors secreted from brown 
adipocytes, “BAT-activity batokines,” which might 
act directly to enhance energy uptake, allowing 
increased thermogenic activity or de novo lipogen-
esis. Slit homolog 2 protein (Slit2) is an example 
of such a batokine (Fig. 2) (40). It was found that 
Slit2 is produced, cleaved into Slit2-C, and secreted 
from murine beige adipocytes in response to 
overexpression of Prdm16, a cotranscription factor 
of the thermogenic gene expression program (55). 
When added as a recombinant peptide, Slit2-C 
amplified energy expenditure and glucose clear-
ance. In support, a later study demonstrated that 
at least the precursor protein, SLIT2, was detected 
in human plasma and negatively correlated with 
plasma glucose levels, raising the idea of a possible 
role in glucose metabolism in humans, although 
further studies will be required to confirm this idea 
(Fig. 2) (56). Slit3 and Epdr1 were also shortlisted 
among the Prdm16- induced proteins in (40) and 
might belong to the same group of batokines. 
EPDR1 (Fig. 2) and SLIT3 were later identified in 
a study of the human brown adipocyte secretome 
(38), and EPRD1 was found to be important for 
differentiation of human thermogenic adipocytes 
(38). Interestingly, the crystal structure of EPDR1 
was recently published, revealing 2 putative lipid-
binding domains (57). A full understanding of the 
function of these proteins in human metabolism 
remains to be established.
BAT adipogenesis and the TGF-β signaling 
pathway
Preadipocytes originate from mesenchymal stem 
cells and both populations are present in the adi-
pose tissue. Upon cold-induced BAT recruitment, 
norepinephrine stimulates proliferation of brown 
preadipocytes, and apoptosis of brown adipocytes 
Figure 2. Brown adipose tissue (BAT) crosstalk in metabolism. Batokines and other factors promoting crosstalk that could be relevant 
for human metabolism. A detailed description of all factors is provided in the text.
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is attenuated, resulting in an accumulation of ac-
tive brown adipocytes as part of a cold acclimation 
(58). Preadipocytes derived from the stromal vas-
cular fraction of adipose tissue differentiate in vitro 
in response to the same differentiation cocktails 
regardless of whether they originate from WAT 
or BAT (59). However, preadipocytes originating 
from BAT are preprogrammed to differen-
tiate into functional brown adipocytes, whereas 
preadipocytes derived from WAT differentiate into 
white adipocytes (28). This seem to occur through 
a sequential interaction between endogenous tran-
scription factors and autocrine growth factors 
(60). Interestingly, not only norepinephrine but 
also batokines secreted from mature adipocytes 
activated by norepinephrine might influence the 
programming.
Many secreted factors affecting brown 
adipogenesis have been reported (19, 38), while 
proteins involved in the transforming growth 
factor (TGF)-β signaling pathway are strikingly 
dominating. This signaling pathway is involved 
from early adipogenic commitment and throughout 
the differentiation into mature adipocytes (Fig. 
3) (19, 33, 61). A  subgroup in the TGF-β super-
family are the bone morphogenic proteins (BMPs). 
These developmental growth factors have been 
described to be important for regulating brown 
adipocyte commitment of preadipocytes or ma-
ture adipocytes in both brown and white adipose 
tissue (62, 63). BMP4 is one of the most studied 
members of the family in terms of adipogenic dif-
ferentiation and is important for both white and 
brown adipogenic commitment (64, 65). Together 
with BMP7, BMP4 promotes early commitment 
towards the brown adipose lineage (66). However, 
whereas BMP7 also facilitates later phases of brown 
adipogenesis (66), the literature on the role of 
BMP4 as selective for brown or white adipogenesis 
is conflicting (66–68); the different studies are 
outlined and discussed in (69). The contradictory 
reports likely reflect the temporal complexity of 
brown and white adipogenesis. BMP4 and BMP7 
share the inhibitor Gremlin-1, which is secreted 
from preadipocytes (68). Another subgroup of the 
TGFβ superfamily are the growth differentiation 
factors (GDFs). Among these, GDF5 and GDF2 
(also known as BMP9) have been reported to en-
hance brown adipogenesis (70), whereas GDF8 
(also known as myostatin) has an inhibiting effect 
(71). This effect is likely related to interactions with 
the brown adipogenesis stimulator, follistatin (72), 
as myostatin and follistatin are antagonizing factors 
(73). Finally, TGF-β and Activin A were shown to 
inhibit brown adipogenesis by blocking the induc-
tion of SREBP-1, an inducer of adipogenesis (74) 
(Fig. 3).
Angiogenesis and BAT recruitment
Although BAT relies on innervation for sym-
pathetic activation, it cannot be excluded that 
hormonal adrenergic stimulation also plays 
an important role. In humans, this is clearly 
exemplified by studies of patients with pheo-
chromocytoma, a catecholamine-producing 
tumor in the adrenal gland. The high circu-
lating endogenous levels of norepinephrine 
in association with this disease results in ex-
tensive BAT recruitment (30, 75). Notably, the 
more vascularized visceral adipose depots also 
acquired thermogenic morphology (30) and 
glucose tracer 18F-FDG uptake (75), while no 
browning was observed in the subcutaneous ad-
ipose depots. Further evidence of vasculariza-
tion as a key mechanism in BAT activity was the 
finding that depletion of VEGFA in murine BAT 
resulted in whitening (76), while overexpression 
of VEGFA induced browning in WAT (77). 
A  similar capillary rarefaction resulting in 
whitening was observed in BAT of diet-induced 
obese mice. Although a similar rarefaction in 
BAT of obese humans has not yet been reported, 
Figure 3. Transforming growth factor (TGF)-β-associated batokines in brown adipogenic commitment and differentiation. Factors part 
of the TGF-β signaling and negative regulators are shown.
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it might contribute to the reduced glucose tracer 
uptake observed in obesity (4, 5).
As mentioned above, initial reports described 
a negative association between BAT activity and 
BMI (4, 5), pointing to a functional inactiva-
tion of BAT in obesity. It was later determined 
that 18F-FDG-positive BAT volume is smaller in 
individuals with obesity and type 2 diabetes (47). 
Furthermore, by applying dynamic PET/CT scan-
ning, BAT glucose uptake rates during acute cold 
exposure were estimated to 90–120 nmol g−1 min−1 
in healthy subjects and 35 nmol g−1 min−1 in obese 
individuals (45). Thus, if only using glucose uptake 
as an estimate of BAT activity, these data would 
support the idea that BAT activity is reduced in 
obesity.
However, other observations suggest that the 
reduction in glucose uptake is not reflecting im-
paired BAT lipid metabolism or BAT thermogen-
esis. This was clearly shown in a human study of 
older overweight individuals with and without type 
2 diabetes compared with young healthy subjects. 
In this study, no reduction in BAT NEFA uptake 
and thermogenic capacity was observed on acute 
cold exposure in the older subjects, although glu-
cose uptake, as expected, was found to be sub-
stantially reduced (47). Interestingly, reduced BAT 
glucose uptake is associated with increased BAT fat 
content (44, 47).
Moreover, whereas human BAT is responsive 
to both insulin and cold (78), this response is se-
verely blunted in obesity (79). Interestingly, BAT 
activation associated with cerebral activity in lean 
subjects, but was blunted in obese subjects (80). 
Taken together, studies in humans suggest an im-
pairment of BAT activation capacity during obesity 
which could be due to regulation both at a central 
and peripheral level.
Indeed, based on the described observations 
in rodents, vascular rarefaction might be part of 
the reduced BAT activity in humans. Importantly, 
human brown adipocytes produce and se-
crete both Vascular endothelial growth factor A 
(VEGFA) and Vascular endothelial growth factor 
D (VEGFD), although VEGFD has not yet been 
explored in gain- or loss-of-function studies (38). 
Importantly, proangiogenic factors also stimulate 
the proliferation and development of human ther-
mogenic preadipocytes (81), further emphasizing 
angiogenesis as a central mechanism in BAT 
recruitment.
Another interesting factor produced by mature 
brown adipocytes and belonging to the TGFβ-
superfamily, is BMP8b (82). BMP8b was shown 
to promote ancillary networks for BAT recruit-
ment by coordinately stimulating both vascular 
and nervous networks (83). The production of 
Neuregulin-4 (NRG4), a batokine-stimulating 
neurite outgrowth, was enhanced by BMP8b as 
were also angiogenic factors, including VEGFA 
(83). NRG4 has also been shown to stimulate an-
giogenesis in adipose tissue, further underlining 
the synchronization of vascularization and neurite 
outgrowth within BAT (83).
Neurite outgrowth in BAT
BAT contains neuronal cells and innervation is 
a key mechanism in BAT recruitment. Increased 
nerve endings will increase exposure to norep-
inephrine during acute activation of BAT. This 
mechanism was recently confirmed in BAT of 
adult humans using 11C-meta-hydroxyephedrin 
and 15O-water PET imaging (84). It was found 
that the level of sympathetic innervation was 
clearly associated with levels of functional BAT 
(84). This was also closely connected with vas-
cularity, as blood flow was the best predictor of 
both sympathetic innervation and functional 
BAT (84). As mentioned above, the recruit-
ment and remodeling of a neurovascular net-
work in BAT is coordinated through induction 
of BMP8b, which is secreted from the activated 
mature brown adipocyte (82). BMP8b induces the 
production of secreted NRG4, which promotes 
sympathetic axon growth and branching in vitro 
and at the same time induces angiogenesis as 
outlined above (83). In adult humans, neuronal 
branching and communication with the central 
nervous system in the context of BAT function 
remains to be studied. Besides modulation of 
local neural networks, the possibility exists that 
BAT also secrets hormones that act on the central 
nervous system like the WAT-produced satiety 
hormone, leptin. Currently, however, there is no 
clear evidence for such a BAT-specific hormone. 
Alternatively, BAT, with its extensive innervation, 
communicates directly through afferent neural 
networks. This idea is supported by a novel study 
discussed below.
BAT and immunometabolism
Since the finding in 2003 that immune cells re-
side in WAT (34, 35), the interactions between 
adipocytes and immune cells has been widely 
studied, and inflammation, fibrosis, and impaired 
adipogenesis have been described as key players 
in adipose tissue dysfunction (85). Studies of dys-
functional WAT in obesity (86) and insulin re-
sistance (87) reveal a reduction in sensitivity to 
β-adrenergic stimulation and subsequent lipol-
ysis, leading to a progressive lipid accumulation. 
Similar dysregulations might occur in BAT, which 
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might explain the observed decreased BAT activity 
with obesity (4, 5). During recent years, the role of 
BAT resident immune cells in regulating BAT ac-
tivity and recruitment has been intensively studied 
and discussed. CXCL14 has been highlighted as 
a novel batokine secreted by thermogenically ac-
tivated brown adipocytes, which recruits alterna-
tively activated macrophages into BAT. This was 
in turn shown to promote adaptive thermogenesis 
and result in M2-mediated browning of the murine 
inguinal depot. This finding relates to an intense 
academic debate on the role of macrophages on 
BAT and beige fat recruitment and thermogenic 
activity (88). As pointed out above, in pheochro-
mocytoma patients excess levels of norepinephrine 
result in BAT recruitment and “browning” of vis-
ceral fat. Norepinephrine is produced in the locus 
coeruleus in the brain as a neurotransmitter and 
can also be synthesized by the prolongation of the 
sympathetic nervous system, the adrenal gland, 
from which it is released as a hormone. A recent 
discussion has centered around the capacity of al-
ternatively activated macrophages for producing 
norepinephrine, providing a direct link between 
immune cells and thermogenesis and BAT recruit-
ment (89, 90). Evidence strongly arguing against 
this mechanism was presented in a follow-up 
study (91). In this context, a separate mechanism 
was presented where sympathetically associated 
macrophages contribute to the clearance within 
BAT, by importing and metabolizing norepineph-
rine (92). Others in the meantime reported that 
macrophages promote BAT innervation (93). 
With focus on the secretome of BAT it was found 
that human brown adipocytes had a differentially 
regulated complement system compared with 
human white adipocytes (38), a finding replicated 
in murine adipocytes with a similar approach (39). 
These findings raise the idea that BAT has other 
immunological properties than WAT which could 
be associated with the presence of BAT at locations 
in adult humans not evidently requiring thermo-
genesis. This includes, eg, the visceral fat regions 
surrounding the kidney (14, 94) and heart (95). 
Altogether, these studies indicate close interactions 
between immune cells and the other cells present 
in BAT.
BAT Crosstalk With Other Organs
BAT-mediated satiety signal from the gut to the 
central nervous system
A crosstalk between BAT, WAT, and the central 
nervous system (CNS) has been described to occur 
via a circuit of sensory neurons in WAT and sym-
pathetic innervation of BAT (96). BAT also exhibits 
afferent neurons, which feedback on brain regions 
controlling sympathetic activation of BAT (97). The 
CNS–BAT circuit is organized in a functional net-
work affected by fluctuations in temperature and 
energy homeostatis, and is in turn adjusting meta-
bolic regulation through sympathetic nerve activity 
of BAT (98). Interestingly, a recent study discovered 
that secretin, a gut peptide, was transported to BAT 
via the circulation and could induce prandial ther-
mogenesis and increased glucose uptake in BAT, in 
turn mediating a satiety signal to the CNS via af-
ferent nerve fibers (99). This raises the conceptual 
idea of BAT as an enhancer of satiety/hunger sig-
nals from the gut and proposes afferent signaling 
as a possible additional important function of BAT. 
Indeed, postprandial induction of thermogenesis 
has been recorded in adult humans at a similar in-
tensity as when stimulated with mild cold (26). It 
is well established that food intake increased at the 
onset of the active phase in rodents (100), coinciding 
with increased BAT activity (101). These everyday 
fluctuations in BAT activity should require strict 
regulation. Whereas fatty acid availability and re-
lease and uptake of norepinephrine certainly are 
major regulators of BAT activity (25), it is likely that 
multiple mechanisms and factors are involved in 
controlling this energy-consuming process.
Batokine-mediated prevention of hepatic 
lipogenesis
Risk factors for excessive storage of fat in the liver, 
besides alcohol overconsumption, include obesity 
and diabetes. This can lead to nonalcoholic fatty 
liver disease (NAFLD), which in turn is associated 
with severe complications including cirrhosis, car-
diovascular disease, and hepatic carcinoma (102). 
BAT activity will increase fatty acid oxidation and 
plasma clearance, but could there be a direct cross-
talk between brown adipocytes and hepatocytes? 
Interestingly, NRG4, mediating both neurite out-
growth and angiogenesis as described above, has 
been reported to increase during brown adipo-
cyte differentiation while decreasing in adipose 
tissue during human obesity (103). It was found 
that NRG4 attenuated diet-induced insulin re-
sistance and a specific effect was reported in the 
liver. Here, NRG4 prevented de novo lipogenesis 
through induction of ErbB3 and ErbB4 signaling 
in hepatocytes (103). In line with these findings, 
decreased serum levels associated with NAFLD in 
children with obesity (103). Importantly, how much 
of the NRG4-dependent antisteatosis effect that is 
mediated by inhibition of de novo lipogenesis and 
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how much that is mediated by increased fatty acid 
oxidation by BAT is currently not known.
The liver-derived hormone FGF21 increases BAT 
thermogenesis
FGF21 is another factor connecting liver with 
BAT. This hormone is produced and secreted 
by the liver and mediates a range of metabolic 
effects on whole-body physiology (104). In 
rodents, Fgf21 is secreted from BAT in response 
to thermogenic activation (105). In human brown 
adipocytes, the expression of FGF21 is close to 
undetectable, and FGF21 was not detected in the 
secretome of human brown adipocytes (38). This 
discrepancy might be related to the differences 
between interscapular BAT (usually analyzed in 
mice) and supraclavicular BAT (usually analyzed 
in human adults) (23) and could in turn be re-
lated to the well-established differences in the 
limited recruited BAT in adult humans compared 
with mice housed at room temperature, a tem-
perature below murine thermoneutrality (106). 
Nevertheless, FGF21 has been shown to enhance 
thermogenesis in human brown adipocytes de-
rived from the neck (107), and as circulating levels 
of FGF21 are elevated in response to ingested glu-
cose (108) and alcohol (109) but not cold (107) 
this protein is likely to be involved in liver–BAT 
crosstalk in humans; however, whether is acts 
as a cold-regulated factor remains to be studied. 
Recent reports have investigated the causal link 
between FGF21-mediated browning and the loss 
of body weight in mice (110–112). Interestingly 
an examination in UCP1 knockout mice (UCP1 
KO) suggests that the effects of FGF21 on weight 
loss and glycemic control (111, 112) as well as 
on thermogenesis (110) are UCP1 independent. 
The role of FGF21 in energy expenditure has 
been discussed in depth (113). It should be noted 
that food intake in response to FGF21 is reduced 
in UCP1 KO and the lack of weight loss is thus 
intriguing (113). In conclusion, more detailed 
studies will be required to delineate both the con-
tribution of BAT to circulating FGF21 levels and 
the role of BAT in mediating the anti-obesogenic 
effects of FGF21.
Loss of IRF4 and myostatin secretion from BAT 
attenuates muscle capacity
Following infancy, skeletal muscle takes over the 
role as the major site of thermogenesis from brown 
adipose tissue in humans (21, 24). Myocytes and 
brown adipocytes are both derived from mesen-
chymal stem cells and share similarities in pre-
cursor transcriptomes (114), in terms of being 
mitochondria-rich and insulin-sensitive cells with 
mitochondria-dependent activity levels that can be 
switched on and off (ie, thermogenesis in BAT and 
contraction in muscle). Despite these similarities, 
there is not yet any documentation of a crosstalk 
between BAT and skeletal muscle in humans. In 
rodents, however, a recent study demonstrated BAT 
to muscle crosstalk, where a loss of the transcription 
factor IRF4 in BAT results in increased transcrip-
tion of myogenic genes, including myostatin (115). 
In skeletal muscle, this alteration in BAT resulted 
in reduced mitochondrial function and dimin-
ished exercise capacity. The upregulation of myo-
genic genes in BAT has previously been reported 
in response to activation of the AgRP neurons 
which impaired insulin-stimulated glucose uptake 
in BAT, while inhibition of myostatin increased in-
sulin sensitivity (116). Thus, BAT upregulation of 
myostatin affects BAT insulin sensitivity as well as 
muscle status and might serve as a mechanism in 
central regulation of glucose homeostasis. To date, 
it remains elusive if a similar mechanism exist in 
humans. From a larger perspective, these findings 
suggest that alterations in BAT affect muscle, and it 
opens the possibility for changes in skeletal muscle 
that could also influence BAT.
Interleukin-6-mediating browning of WAT?
Interleukin (IL)-6 is a multifunctional cytokine 
with contextual functions either as part of an 
acute inflammatory response or as a myokine 
promoting muscle glucose uptake and myogenesis 
(117, 118). IL-6 has also been proposed to play a 
role in exercise-induced “browning” of WAT as 
expression of marker genes for this process was 
blunted in IL-6 knockout mice (119). Browning 
represents the mechanism where WAT acquires 
a thermogenic phenotype (120, 121). In further 
support of IL-6 mediating browning, the benefi-
cial effects on glucose homeostasis of BAT trans-
plantation into the WAT depot disappeared when 
transplanting BAT from IL-6 knockout mice 
(122). The precise mechanism for IL-6-mediated 
browning and whether it is relevant in humans 
remains to be investigated. IL-6 is upregulated 
in the circulation following acute exercise (123), 
and multiple studies have assessed the effect of 
exercise on browning in humans. Interestingly 
multiple studies point to the fact that browning is 
not induced by exercise in human subcutaneous 
fat (124–127). A reason for this might be the lim-
ited innervation and vascularization of the sub-
cutaneous abdominal adipose depot. Given the 
browning capacity of the visceral adipose depot 
observed in patients with pheochromocytoma, it 
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could be argued that this depot would be the most 
relevant to study when addressing the occurrence 
of WAT browning in adult humans. However, 
obtaining human visceral adipose tissue is not 
trivial and is mostly done in conjunction with a 
surgical intervention.
Perspectives
Adult humans have BAT and this tissue plays 
a role in whole-body metabolism (16); re-
cent studies strongly suggest a whole-body 
crosstalk which involves BAT. Given the met-
abolic properties of WAT, it is intriguing to as-
sess whether BAT secretes an equally potent 
hormone as the key metabolic regulator leptin 
(128). However, due to the extensive innervation 
of BAT, and the newly presented mechanism for 
secretin signaling, it is also worthwhile to fur-
ther explore the afferent neural signaling from 
BAT to the CNS. In relation to this, it should 
be noted that the residual BAT in adult humans 
seems closely connected with the central nervous 
system by location (Fig. 4). Thus, the potential 
of peptide exchange between BAT and neigh-
boring neurons warrants further investigation. 
Moreover, to study whether additional signaling 
peptides from metabolic tissues such as gut, 
liver, pancreas, and muscle target BAT with a 
forwarding effect to the CNS will be an exciting 
research area in the future. Finally, an important 
Figure 4. A cartoon showing representative brown adipose tissue (BAT) occurrence in relation to the central nervous system in an 
adult human.
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open question is: Which factors are 
mediating the age-dependent inac-
tivation of BAT? (16, 22). Gradually 
turning off the energy-consuming 
activity of BAT might be beneficial 
from an evolutionary perspective and 
is thus putatively actively regulated. 
Identifying novel batokines involved 
in the above-discussed processes is a 
promising avenue for the discovery 
of drug targets promoting metabolic 
health.
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